Bank of America’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-178
Closed -$1K 7659
2015
Q2
$1K Buy
178
+154
+642% +$1.09K ﹤0.01% 7197
2015
Q1
$0 Sell
24
-71
-75% -$732 ﹤0.01% 7973
2014
Q4
$1K Buy
95
+86
+956% +$1.17K ﹤0.01% 7609
2014
Q3
$0 Sell
9
-3,187
-100% -$46.3K ﹤0.01% 8367
2014
Q2
$50K Buy
+3,196
New +$48.5K ﹤0.01% 6665

Other funds holding TRIV

Bank of America's TRIV Position: Q3 2015 in Review

Bank of America sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q3 2015, closing a stake of 178 shares — an estimated $1K sold.

Bank of America first reported a position in TRIV in Q2 2014 and held it in 5 quarters. The position peaked at $50K in Q2 2014. 26 funds tracked by Wall St. Rank hold TRIV as of Q3 2015.

  • Bank of America reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q3 2015 after selling out during the quarter.
  • Bank of America sold 178 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q3 2015, an estimated $1K.
  • Bank of America first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 5 quarters.
  • Bank of America's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $50K in Q2 2014.
  • 26 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q3 2015.

Based on Bank of America's 13F filing for Q3 2015, filed 16 Nov 2015.